WASHINGTON (Axios): Sanofi announced Monday it will manufacture up to 200 million doses of Moderna’s COVID-19 vaccine at its site in Ridgefield, New Jersey, from September.
Why it matters: The agreement between Sanofi and Moderna should not only boost the U.S. coronavirus vaccine rollout, it should also help global efforts as the doses will likely be exported.
Of note: French multinational pharmaceutical giant Sanofi is the only manufacturer that is producing doses of the Pfizer-BioNTech, Johnson & Johnson and now Moderna, in addition to developing two of its own coronavirus vaccines.
The big picture: More than 1 billion COVID-19 doses have now been produced. The U.S. has administered the most — 23% of the worldwide total, statistics from Our World in Data show.
The World Health Organization earlier this month criticized a “shocking imbalance” in vaccine distribution, with poorer nations being left behind.
While the U.S. has kept nearly all of its supply for domestic use, it’s expected to become a major exporter once its domestic needs are met.
F.P. Report KARACHI: The Sindh government has decided to bring in more buses for the…
F.P. Report PESHAWAR: Khyber Pakhtunkhwa Chief Minister Ali Amin Gundapur has threatened to take over…
Humayun Khan PESHAWAR: Chief Justice Peshawar High Court (PHC) Justice Ishtiaq Ibrahim ordered Chief Secretary,…
F.P. Report KARACHI : Pakistan International Airlines flight from Islamabad to Toronto has been diverted…
F.P. Report ISLAMABAD: Chief Justice Aamer Farooq of the Islamabad High Court (IHC) on Friday…
F.P. Report RAWALPINDI: General Syed Asim Munir, NI (M), Chief of Army Staff (COAS), received…
This website uses cookies.